Literature DB >> 31840027

Social Determinants of Polypharmacy in First Generation Mexican Immigrants in the United States.

Shervin Assari1, Mohammed Saqib2, Cheryl Wisseh1,3, Mohsen Bazargan1,4.   

Abstract

INTRODUCTION: Socioeconomic status (SES) indicators are among the main social determinants of health and illness. Less, however, is known about the role of SES in the epidemiology of polypharmacy in immigrant Latino Americans living in the United States. This research studied the association between three SES indicators, education, income, and employment, and polypharmacy in older first generation Latino American immigrant adults.
METHODS: Data was obtained from the Sacramento Area Latino Study on Aging (SALSA, 1996-2008). A total of 632 older first generation Mexican-American immigrants to the U.S. entered this analysis. The independent variables were education, income, and employment. Polypharmacy was the outcome. Age, gender, physical health, smoking, and drinking were the covariates. Binary logistic regression was used to analyze the data.
RESULTS: Employment was associated with lower odds of polypharmacy. The association between education and polypharmacy was above and beyond demographic factors, physical health, health behaviors, and health insurance. Neither education nor income were associated with polypharmacy. Other determinants of polypharmacy were poor self-rated health (SRH) and a higher number of chronic medical conditions (CMCs).
CONCLUSION: Employment appears to be the major SES determinant of polypharmacy in older foreign-born Mexican Americans. Unemployed older Mexican American immigrants with multiple chronic diseases and those who have poor SRH have the highest need for an evaluation of polypharmacy. Given the age group of this population, most of them have health insurance, which provides an opportunity for reducing their polypharmacy.

Entities:  

Keywords:  Educational Achievement; Ethnic Groups; Immigrants; Income; Mexican American; Polypharmacy

Year:  2019        PMID: 31840027      PMCID: PMC6910246          DOI: 10.15171/ijtmgh.2019.19

Source DB:  PubMed          Journal:  Int J Travel Med Glob Health        ISSN: 2322-1100


  25 in total

Review 1.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  "Take ten minutes": a dedicated ten minute medication review reduces polypharmacy in the elderly.

Authors:  E K Walsh; K Cussen
Journal:  Ir Med J       Date:  2010-09

3.  Combined Racial and Gender Differences in the Long-Term Predictive Role of Education on Depressive Symptoms and Chronic Medical Conditions.

Authors:  Shervin Assari
Journal:  J Racial Ethn Health Disparities       Date:  2016-06-07

Review 4.  Association between polypharmacy and death: A systematic review and meta-analysis.

Authors:  Nattawut Leelakanok; Andrea L Holcombe; Brian C Lund; Xiaomei Gu; Marin L Schweizer
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-05

5.  Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging.

Authors:  Adina Zeki Al Hazzouri; Mary N Haan; John D Kalbfleisch; Sandro Galea; Lynda D Lisabeth; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

6.  Cross-Country Differences in the Additive Effects of Socioeconomics, Health Behaviors and Medical Comorbidities on Disability among Older Adults with Heart Disease.

Authors:  Shervin Assari
Journal:  J Tehran Heart Cent       Date:  2015-01-08

7.  Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.

Authors:  Joanna Ulley; Deborah Harrop; Ali Ali; Sarah Alton; Sally Fowler Davis
Journal:  BMC Geriatr       Date:  2019-01-18       Impact factor: 3.921

8.  Polypharmacy in African American Adults: A National Epidemiological Study.

Authors:  Shervin Assari; Hamid Helmi; Mohsen Bazargan
Journal:  Pharmacy (Basel)       Date:  2019-03-29

9.  Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country.

Authors:  Kerryn S Armstrong; Henk Temmingh
Journal:  Braz J Psychiatry       Date:  2017-02-06       Impact factor: 2.697

10.  Trends in polypharmacy over 12 years and changes in its social gradients in South Korea.

Authors:  Yeon-Hee Baek; Ju-Young Shin
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.